Trustmark National Bank Trust Department’s iShares Biotechnology ETF IBB Stock Holding History

Trustmark National Bank Trust Department’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-270	Closed	-$29K	–	373
2019 Q2	$29K	Hold	270	–	–	﹤0.01%	405
2019 Q1	$30K	Hold	270	–	–	﹤0.01%	394
2018 Q4	$26K	Hold	270	–	–	﹤0.01%	393
2018 Q3	$33K	Buy	+270	New	+$31.8K	﹤0.01%	396

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Trustmark National Bank Trust Department's IBB Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 270 shares — an estimated $29K sold.

Trustmark National Bank Trust Department first reported a position in IBB in Q3 2018 and held it in 4 quarters. The position peaked at $33K in Q3 2018. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 270 iShares Biotechnology ETF shares in Q3 2019, an estimated $29K.
Trustmark National Bank Trust Department first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 4 quarters.
Trustmark National Bank Trust Department's iShares Biotechnology ETF position peaked at $33K in Q3 2018.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.